Replies to post #41354 on Biotech Values

[EyeGuy]

The company's assertion that "ATG3 is the first non-invasive eye drop therapy for AMD that has entered the clinic..." is not completely true.

See http://www.othera.com/pdfs/Othera_NEI_Dry_AMD_Study.pdf